This is only an anecdotal evidence from my work place but we are performing a lot more respiratory viruses panel which includes covid, flu A and B and RSV etc.. I'm seeing lots of flu cases going around. Leads me to believe this quarter would be good for gss. Once gss shows that they can sustain same level of revenue, they'll pop off imo
News: GSS Genetic Signatures Says Quarterly Sales Of A$8.7 Million, Up 108% On Q3 Fy2021, page-9
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $172.1M | |||
| Open | High | Low | Value | Volume |
| 76.0¢ | 76.0¢ | 76.0¢ | $35.37K | 46.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 8159 | 74.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.0¢ | 10334 | 1 |
View Market Depth
| Last trade - 13.51pm 12/07/2024 (20 minute delay) ? |
| GSS (ASX) Chart |